DekaBank Deutsche Girozentrale’s Insys Therapeutics, Inc. INSY Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-28,500	Closed	-$304K	–	1330
2019 Q1	$304K	Buy	28,500 +5,500	+24%	+$26K	﹤0.01%	992
2018 Q4	$81K	Sell	23,000 -5,500	-19%	-$38.2K	﹤0.01%	1092
2018 Q3	$304K	Sell	28,500 -500	-2%	-$3.99K	﹤0.01%	1014
2018 Q2	$214K	Hold	29,000	–	–	﹤0.01%	1036
2018 Q1	$176K	Sell	29,000 -8,700	-23%	-$71.8K	﹤0.01%	1005
2017 Q4	$357K	Hold	37,700	–	–	﹤0.01%	879
2017 Q3	$357K	Hold	37,700	–	–	﹤0.01%	885
2017 Q2	$487K	Hold	37,700	–	–	﹤0.01%	840
2017 Q1	$414K	Sell	37,700 -3,500	-8%	-$37.3K	﹤0.01%	770
2016 Q4	$375K	Buy	41,200 +3,100	+8%	+$35K	﹤0.01%	708
2016 Q3	$460K	Hold	38,100	–	–	0.01%	679
2016 Q2	$477K	Buy	38,100 +7,100	+23%	+$103K	0.01%	688
2016 Q1	$492K	Sell	31,000 -5,500	-15%	-$104K	0.01%	658
2015 Q4	$1.07M	Buy	36,500 +600	+2%	+$16.6K	0.01%	562
2015 Q3	$1.02M	Buy	35,900 +1,700	+5%	+$62.6K	0.01%	553
2015 Q2	$1.23M	Buy	34,200 +1,400	+4%	+$43.6K	0.01%	530
2015 Q1	$953K	Sell	32,800 -4,100	-11%	-$108K	0.01%	578
2014 Q4	$773K	Sell	36,900 -3,400	-8%	-$67.2K	0.01%	609
2014 Q3	$781K	Buy	40,300 +1,000	+3%	+$15.7K	0.01%	558
2014 Q2	$614K	Buy	39,300 +13,100	+50%	+$212K	0.01%	572
2014 Q1	$543K	Buy	+26,200	New	+$520K	0.01%	562

Other funds holding INSY

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

DekaBank Deutsche Girozentrale's INSY Position: Q2 2019 in Review

DekaBank Deutsche Girozentrale sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 28,500 shares — an estimated $304K sold.

DekaBank Deutsche Girozentrale first reported a position in INSY in Q1 2014 and held it in 21 quarters. The position peaked at $1.23M in Q2 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

DekaBank Deutsche Girozentrale reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 28,500 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $304K.
DekaBank Deutsche Girozentrale first reported a position in Insys Therapeutics, Inc. in Q1 2014 and held it in 21 quarters.
DekaBank Deutsche Girozentrale's Insys Therapeutics, Inc. position peaked at $1.23M in Q2 2015.
16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2019, filed 1 Aug 2019.